Neuronetics SEC Filings

Schedule 13G Filing – iOThree Limited (Ticker: IOTR)

The filing discloses the beneficial ownership of iOThree Limited’s ordinary shares (par value $0.00625) as of 30 June 2025. A total of 25,650,000 ordinary shares are stated as issued and outstanding. Three reporting persons cross-filed the statement:

• Eng Chye Koh (Singapore citizen) – 19,209,600 shares, representing 74.89 % of the outstanding class, with sole voting and dispositive power.
• iO3 Strategic Investments Ltd. (British Virgin Islands) – 14,282,400 shares, representing 55.68 %, with sole voting and dispositive power.
• All Wealthy International Ltd. (British Virgin Islands) – 4,927,200 shares, representing 19.21 %, with sole voting and dispositive power.

The percentages are calculated by each filer against the same 25.65 million share base. Each filer certifies no shared voting or dispositive authority. The reporting persons have executed a joint filing agreement (Exhibit 1) and attest that the information is true, complete and correct as of the signature date, 15 July 2025.

Key observations for investors:

• Eng Chye Koh alone exceeds the 50 % threshold, implying effective control of corporate actions requiring shareholder approval.
• Two British Virgin Islands entities—likely investment vehicles—also cross the 5 % reporting threshold, further concentrating ownership.
• Because the combined disclosed stakes are well above 80 % of total shares, the effective public float appears limited, which may affect trading liquidity and governance dynamics.

Neuronetics, Inc. (Nasdaq: STIM) filed an 8-K on 15 July 2025 announcing a key leadership change. The Board appointed Steven Pfanstiel (age 52) as Executive Vice President, Chief Financial Officer and Treasurer, effective immediately.

Professional background: Pfanstiel most recently held CFO and COO posts at Marinus Pharmaceuticals (2021-2025) and previously served in senior finance roles at LifeScan, OptiNose and Johnson & Johnson subsidiaries. His academic credentials include a B.A. in Physics, an M.S. in Environmental Systems Engineering and an MBA.

Compensation package:

• Base salary: $480,000
• Target annual bonus: 50 % of base
• Equity grant: 400,000 restricted stock units—half vest over 1-3 years and half over 2-4 years, contingent on continued service
• Severance (termination without cause or for good reason): 12 months base salary, prorated target bonus and continued health coverage

Mr. Pfanstiel signed the Company’s standard indemnification, restrictive-covenant and invention-assignment agreements.

Regulation FD disclosure: The accompanying press release (Exhibit 99.1) both announces the appointment and reaffirms previously issued Q2 and FY-2025 financial guidance. No new numerical guidance was provided.

Investor takeaway: The hire adds a seasoned life-sciences finance executive ahead of anticipated growth initiatives, while the reiterated outlook signals management confidence in near-term performance.

Form 4 highlights the final step in Redfin Corporation’s (RDFN) merger with Rocket Companies, Inc. Director James Slavet reported the disposition of all Redfin common shares on 07/01/2025 pursuant to the previously announced Agreement and Plan of Merger dated 03/09/2025. At the effective time, every share of Redfin common stock was automatically converted into the right to receive 0.7926 shares of Rocket Companies Class A common stock plus cash in lieu of fractional shares. As a result, Slavet now holds 0 Redfin shares; any continuing economic interest is now represented by Rocket equity.

The filing confirms that Redfin has become a wholly owned subsidiary of Rocket Companies, ending its status as an independent publicly traded entity. The disposition code “D” and accompanying footnote make clear that the transaction was non-discretionary, occurring solely because of the merger terms rather than an open-market sale.

Key takeaways for investors:

• Merger completion date: 07/01/2025.
• Exchange ratio: 0.7926 Rocket Class A shares for each Redfin share.
• Impact on RDFN stock: Shares are cancelled; holders should now expect Rocket (RKT) shares and any cash for fractions.